Cochlear's earnings point to further problems

Earnings were mostly in line with expectations. But Cochlear is facing an uncertain future on regulatory and competitive fronts.

Cochlear (COH), the celebrated hearing implant pioneer, has experienced its fair share of disappointments in the past two years.

And it is discovering that rehabilitating a reputation can be a long and difficult road. Its full-year results this morning, with revenue and earnings marginally weaker than its lowered expectations, sparked an early wave of selling.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles